XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.1
SEGMENT REPORTING
 3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
SEGMENT REPORTING

NOTE 11 - SEGMENT REPORTING

FASB Codification Topic 280, Segment Reporting, establishes standards for reporting financial and descriptive information about an enterprise’s reportable segments. The Company has two reportable segments: the design, manufacture, assembly and distribution of disinfecting systems for use in healthcare, hospitality, and commercial municipal and residential markets (disinfectant segment) and the manufacture of fine mirrors specifically for the hospitality industry (hospitality segment). The segments are determined based on several factors, including the nature of products and services, the nature of production processes, customer base, delivery channels and similar economic characteristics.

An operating segment’s performance is evaluated based on its pre-tax operating contribution, or segment income. Segment income is defined as net sales less cost of sales, segment selling, general and administrative expenses, research and development costs and stock-based compensation. It does not include other charges (income), net and interest and other, net.

Schedule of segment reporting                     
   Hospitality  Disinfection/Healthy Building Technologies  Corporate  Total
Balance sheet at March 31, 2023                     
Assets   $10,738,154   $59,698,939   $2,516,239   $72,953,332 
Liabilities   $10,306,177   $29,743,519   $9,332,394   $49,382,090 
Balance sheet at December 31, 2022                     
Assets   $9,638,828   $19,831,097   $3,257,502   $32,727,427 
Liabilities   $10,666,643   $1,545,217   $3,281,672   $15,493,532 

 

   Hospitality  Disinfection/Healthy Building technologies  Corporate  Total
Income Statement for the three months ended March 31, 2023:                    
Net Sales  $6,081,373   $4,573,110   $—    $10,654,483 
Cost of Goods Sold  $5,306,186   $3,425,911   $—    $8,732,097 
Research and development  $—    $189,210   $—    $189,210 
Stock based compensation  $56,854   $36,176   $96,585   $189,615 
Income Statement for the three months ended March 31, 2022:                    
Net Sales  $1,409,250   $1,946,840   $—    $3,356,090 
Cost of Goods Sold  $1,158,644   $1,048,347   $—    $2,206,991 
Research and development  $—    $59,314   $—    $59,314 
Stock based compensation  $86,011   $22,286   $179,702   $287,999 
Loss on impairment of goodwill  $—    $1,138,203   $—    $1,138,203 
Selling, General and Administrative expenses  $659,088   $1,785,210   $368,929   $2,813,227